Medicenna Therapeutics (MDNA) Competitors

C$0.95 +0.01 (+1.06%)

As of 11:43 AM Eastern

MDNA vs. VBV, CUS, AIM, IPA, GPH, APM, GXE, CRDL, CGC, and WMD

Should you be buying Medicenna Therapeutics stock or one of its competitors? The main competitors of Medicenna Therapeutics include VBI Vaccines (VBV), Chemtrade Electrochem Inc, (CUS), Aimia (AIM), ImmunoPrecise Antibodies (IPA), Graphite One (GPH), Andean Precious Metals (APM), Gear Energy (GXE), Cardiol Therapeutics (CRDL), Canadian Gold (CGC), and WeedMD (WMD). These companies are all part of the "pharmaceutical products" industry.

Medicenna Therapeutics vs. Its Competitors

Medicenna Therapeutics (TSE:MDNA) and VBI Vaccines (TSE:VBV) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends and institutional ownership.

: Medicenna Therapeutics has higher earnings, but lower revenue than VBI Vaccines. Medicenna Therapeutics is trading at a lower price-to-earnings ratio than VBI Vaccines, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Medicenna Therapeutics N/A N/A -C$25.98M -C$0.16 -5.94
VBI Vaccines C$3.36M 0.00 -C$62.16M -C$0.97 N/A
: VBI Vaccines has a net margin of 0.00% compared to Medicenna Therapeutics' net margin of -533,640.00%. VBI Vaccines' return on equity of 0.00% beat Medicenna Therapeutics' return on equity.
Company Net Margins Return on Equity Return on Assets
Medicenna Therapeutics -533,640.00% -159.88% -32.80%
VBI Vaccines N/A N/A N/A
: 0.4% of Medicenna Therapeutics shares are owned by institutional investors. 22.6% of Medicenna Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
: In the previous week, Medicenna Therapeutics' average media sentiment score of 0.00 equaled VBI Vaccines'average media sentiment score.
Company Overall Sentiment
Medicenna Therapeutics Neutral
VBI Vaccines Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medicenna Therapeutics	N/A	N/A	-C$25.98M	-C$0.16	-5.94
VBI Vaccines	C$3.36M	0.00	-C$62.16M	-C$0.97	N/A

Company	Net Margins	Return on Equity	Return on Assets
Medicenna Therapeutics	-533,640.00%	-159.88%	-32.80%
VBI Vaccines	N/A	N/A	N/A

Company	Overall Sentiment
Medicenna Therapeutics	Neutral
VBI Vaccines	Neutral

Summary

VBI Vaccines beats Medicenna Therapeutics on 5 of the 9 factors compared between the two stocks.

Get Medicenna Therapeutics News Delivered to You Automatically

Subscribe Now

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MDNA vs. The Competition

Export to Excel

Metric	Medicenna Therapeutics	Biotechnology Industry	Medical Sector	TSE Exchange
Market Cap	C$79.24M	C$230.64M	C$6.07B	C$9.51B
Dividend Yield	N/A	3.80%	5.66%	6.48%
P/E Ratio	-5.94	95.53	85.53	26.38
Price / Sales	N/A	6,052.46	588.18	12.98
Price / Cash	1.15	13.19	38.32	83.29
Price / Book	3.64	110.04	12.77	5.73
Net Income	-C$25.98M	-C$90.99M	C$3.30B	C$301.20M
7 Day Performance	-4.04%	0.63%	1.85%	0.03%
1 Month Performance	-8.65%	6.08%	8.45%	5.77%
1 Year Performance	-57.01%	696.53%	80.37%	40.62%

Medicenna Therapeutics Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MDNA Medicenna Therapeutics	N/A	C$0.95 +1.1%	N/A	-56.3%	C$79.24M	N/A	-5.94	20
VBV VBI Vaccines	N/A	N/A	N/A	N/A	C$308.86M	C$3.36M	-4.97	22
CUS Chemtrade Electrochem Inc,	N/A	N/A	N/A	N/A	C$306.50M	N/A	0.00	60
AIM Aimia	3.0049 of 5 stars	C$3.16 +0.6%	C$4.00 +26.6%	+26.3%	C$287.42M	C$486.40M	-39.50	20	Positive News
IPA ImmunoPrecise Antibodies	N/A	C$6.50 +0.8%	N/A	+0.0%	C$162.08M	C$19.47M	-7.30	80	Gap Down
GPH Graphite One	N/A	C$0.95 -3.1%	N/A	+88.2%	C$153.00M	N/A	-15.83	20	News Coverage Gap Up
APM Andean Precious Metals	2.3621 of 5 stars	C$1.29 +7.5%	C$2.00 +55.0%	-16.8%	C$135.47M	C$154.78M	2.55	30	Positive News
GXE Gear Energy	N/A	N/A	N/A	N/A	C$126.52M	C$134.93M	10.39	1,310
CRDL Cardiol Therapeutics	N/A	C$1.45 -3.3%	N/A	-39.1%	C$121.41M	N/A	-3.02	20
CGC Canadian Gold	N/A	C$0.45 -1.1%	N/A	+166.7%	C$92.81M	N/A	-22.25	3,150
WMD WeedMD	N/A	C$0.28 -1.8%	N/A	+0.0%	C$67.82M	C$27.53M	-0.66	628	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:MDNA) was last updated on 10/10/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Medicenna Therapeutics (MDNA) Competitors

MDNA vs. VBV, CUS, AIM, IPA, GPH, APM, GXE, CRDL, CGC, and WMD

Medicenna Therapeutics vs. Its Competitors

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDNA vs. The Competition

Medicenna Therapeutics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Medicenna Therapeutics (MDNA) Competitors

MDNA vs. VBV, CUS, AIM, IPA, GPH, APM, GXE, CRDL, CGC, and WMD

Medicenna Therapeutics vs. Its Competitors

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDNA vs. The Competition

Medicenna Therapeutics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools